Continuing education
In terms of continuing education, the Graduate School of One Health-Emerging Infectious Diseases offers validation of professional experience (VAP) or validation of experience (VAE) at both Master’s and Doctorate levels, and University Diplomas (DU) and MOOCs.
The DUs of Université Paris Cité and Institut Pasteur cover extremely broad fields in the field of omics, bioinformatics, microbiology, virology, etc. and more specifically on emerging infectious diseases (modelling of infectious diseases, clinical trials in infectious diseases, insect vectors and transmission of pathogenic agents, etc.).
Find the replays of our webinars here.
For any questions, please contact: gradschool.1health-eid@u-paris.fr
Read more
The Graduate School 1H-EID Brings Academia and Industry Together to Tackle Emerging Infectious Diseases
On 14 October, the Graduate School One Health – Emerging Infectious Diseases at Université Paris Cité hosted an evening of discussion and networking between academic and industry stakeholders at the François Jacob Amphitheatre of Institut Pasteur, focusing on a key...
Welcome to the 2026-2027 class of the Master 2 and PhD in Emerging Infectious Diseases!
What better way to kick off the academic year than with an apéro on the banks of the Seine? To mark the start of the new academic year, the Graduate School of One Health – Emerging Infectious Diseases organized a convivial evening bringing together the new Master 2...
The MIcrobeS Doctoral School: a strategic framework for doctoral training in microbiology and infectious diseases at Université Paris Cité
At the start of the 2026 academic year, the Microorganisms and Infection Doctoral School (MIcrobeS) officially opened at Université Paris Cité. This doctoral school, at the heart of today’s major scientific and health challenges, aims to train a new generation of...
AMR Horizons 2026: Three Days to Rethink Antimicrobial Resistance
From 8 to 10 July 2026, the Graduate Schools Antimicrobial Resistance and One Health – Emerging Infectious Diseases brought together researchers, healthcare professionals, representatives from industry, and students in Paris to address a shared challenge:...